Treatment of Adolescent Obesity in 2020

Michelle I. Cardel; Ania M. Jastreboff; Aaron S. Kelly

doi:10.1001/jama.2019.14725

Treatment of Adolescent Obesity in 2020

Michelle I. Cardel
, Ania M. Jastreboff
, Aaron S. Kelly

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	1707-1708
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	322
Issue number	17
DOIs	https://doi.org/10.1001/jama.2019.14725
State	Published - Nov 5 2019

Bibliographical note

Funding Information:
reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study. Dr Kelly reported serving as an unpaid advisor to Novo Nordisk, Vivus, Orexigen, Takeda, and WW [Weight Watchers] and receiving research support from AstraZeneca for an NIH-funded clinical trial. Dr Jastreboff reported receiving personal fees from and serving as a consultant for Novo Nordisk and Medtronic Diabetes and receiving personal fees from Rhythm Pharmaceuticals.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1001/jama.2019.14725

Find It

Find It at U of M Libraries

Cite this

@article{31d449a707aa4fef88087f3a4c9a2852,

title = "Treatment of Adolescent Obesity in 2020",

author = "Cardel, \{Michelle I.\} and Jastreboff, \{Ania M.\} and Kelly, \{Aaron S.\}",

note = "Funding Information: reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study. Dr Kelly reported serving as an unpaid advisor to Novo Nordisk, Vivus, Orexigen, Takeda, and WW [Weight Watchers] and receiving research support from AstraZeneca for an NIH-funded clinical trial. Dr Jastreboff reported receiving personal fees from and serving as a consultant for Novo Nordisk and Medtronic Diabetes and receiving personal fees from Rhythm Pharmaceuticals.",

year = "2019",

month = nov,

day = "5",

doi = "10.1001/jama.2019.14725",

language = "English (US)",

volume = "322",

pages = "1707--1708",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "17",

}

TY - JOUR

T1 - Treatment of Adolescent Obesity in 2020

AU - Cardel, Michelle I.

AU - Jastreboff, Ania M.

AU - Kelly, Aaron S.

N1 - Funding Information: reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study. Dr Kelly reported serving as an unpaid advisor to Novo Nordisk, Vivus, Orexigen, Takeda, and WW [Weight Watchers] and receiving research support from AstraZeneca for an NIH-funded clinical trial. Dr Jastreboff reported receiving personal fees from and serving as a consultant for Novo Nordisk and Medtronic Diabetes and receiving personal fees from Rhythm Pharmaceuticals.

PY - 2019/11/5

Y1 - 2019/11/5

UR - https://www.scopus.com/pages/publications/85072764016

UR - https://www.scopus.com/pages/publications/85072764016#tab=citedBy

U2 - 10.1001/jama.2019.14725

DO - 10.1001/jama.2019.14725

M3 - Short survey

C2 - 31566652

AN - SCOPUS:85072764016

SN - 0098-7484

VL - 322

SP - 1707

EP - 1708

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 17

ER -

Treatment of Adolescent Obesity in 2020

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Cite this